Xiao, Fenglong – Trademark Portfolio
Entity Type: 01
Xiao, Fenglong holds 10 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 26 (Fancy Goods) — 8 filings in this category. The portfolio also extends into Class 3 (Cosmetics & Cleaning) across 3 Nice Classification classes. Currently, 5 trademarks are registered and 3 are pending. Notable registered marks include SKENI, ALLOVE, SEELOVE, MAIYOTEN, and OAHOBEAUTY. The owner is based in Qingdao, Shandong.
No.7, Hongkong East Road,
Shinan District,
Qingdao, Shandong 266071 , CN
Showing of trademarks Trademarks
Trademark Classifications
Xiao, Fenglong's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Lace and embroidery, ribbons and braid; buttons, hooks and eyes, pins and needles
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Games and playthings; gymnastic and sporting articles; decorations for Christmas trees
Frequently Asked Questions
How many trademarks does Xiao, Fenglong have?
Xiao, Fenglong has 10 U.S. trademarks filed with the USPTO. Of these, 5 registered, 3 pending, 2 abandoned.
What trademark classes does Xiao, Fenglong file in?
Xiao, Fenglong files trademarks across 3 Nice Classification classes. The most active classes are Class 26 (Fancy Goods), Class 3 (Cosmetics & Cleaning), Class 28 (Toys & Sporting Goods). Class 26 covers lace and embroidery, ribbons and braid; buttons, hooks and eyes, pins and needles.
What are Xiao, Fenglong's most well-known trademarks?
Xiao, Fenglong's registered trademark portfolio includes well-known marks such as SKENI, ALLOVE, SEELOVE, MAIYOTEN, and OAHOBEAUTY. These are among 5 currently registered trademarks in the portfolio.
What is Xiao, Fenglong's trademark registration success rate?
Xiao, Fenglong has a 71% trademark registration rate, with 5 out of 7 resolved applications resulting in successful registration. Currently, 3 applications are pending review.